Valuation: Precipio, Inc.

Market Cap 42.68M 37.46M 35.21M 32.19M 60.16M 4.09B 60.6M 423M 164M 2.08B 160M 157M 6.76B P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 43.68M 38.34M 36.04M 32.95M 61.57M 4.18B 62.03M 433M 168M 2.13B 164M 160M 6.92B EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.32%
Yield 2024 *
-
Yield 2025 -
1 day-9.23%
1 week-10.58%
Current month-13.90%
1 month-21.71%
3 months+2.76%
6 months-11.47%
Current year+3.74%
1 week 23.58
Extreme 23.58
27.04
1 month 23.58
Extreme 23.58
32.57
Current year 19.22
Extreme 19.22
33.63
1 year 16.4
Extreme 16.4
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
61.8
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 31/05/2017
Chief Executive Officer 54 27/06/2017
Director TitleAgeSince
Director/Board Member 54 27/06/2017
Director/Board Member 78 25/09/2017
Director/Board Member 67 07/11/2017
Date Insider Type Main position Quantity % Market Cap. Importance
15/07/26 Free

Director

520 0.0291%
15/07/26 Free

Director

416 0.0233%
15/07/26 Free

Director

108 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
-9.23%-10.58%+32.59%+325.71% 42.68M
+0.53%+2.34%+25.30%-19.54% 18.05B
+1.81%+3.74%-37.25%+30.15% 1.95B
-1.70%-0.16%-32.50%+24.00% 881M
-0.16%-0.11%+51.85%-2.02% 778M
-5.48%-3.99%-62.32%-85.56% 709M
+0.70%+9.49%-29.46%-46.23% 691M
-0.03%+0.70%-37.89%-52.09% 579M
-2.15%+10.28%+44.90%+81.13% 452M
+1.37%+2.18%-3.99%+5.38% 404M
Average -1.53%+2.25%-4.88%+26.09% 2.45B
Weighted average by Cap. +0.28%+4.09%+13.41%-14.03%

Financials

2024 2025
Net sales 18.53M 16.27M 15.29M 13.98M 26.12M 1.78B 26.32M 184M 71.2M 905M 69.59M 68.07M 2.93B 24.05M 21.11M 19.84M 18.14M 33.9M 2.3B 34.15M 238M 92.39M 1.17B 90.31M 88.33M 3.81B
Net income -4.29M -3.77M -3.54M -3.24M -6.05M -411M -6.09M -42.51M -16.48M -210M -16.11M -15.76M -679M -363K -319K -299K -274K -512K -34.77M -515K -3.6M -1.39M -17.73M -1.36M -1.33M -57.48M
Net Debt -136K -119K -112K -103K -192K -13.03M -193K -1.35M -522K -6.64M -511K -500K -21.53M 1M 879K 827K 756K 1.41M 95.98M 1.42M 9.93M 3.85M 48.94M 3.76M 3.68M 159M
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
23/09/26 US$23.84 -9.23% 39,744
22/09/26 US$26.27 -1.96% 80,490
21/09/26 US$26.79 +1.25% 138,389
18/09/26 US$26.46 +0.08% 192,263
17/09/26 US$26.44 -0.83% 406,720
  1. Stock Market
  2. Stocks
  3. PRPO Stock